A Clinical Outcomes and Safety Trial in Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume

Grants and Contracts Details

StatusFinished
Effective start/end date4/20/0910/31/10

Funding

  • Cubist Pharmaceuticals Inc: $40,987.00